Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Metagenomi Therapeutics, Inc. - Common Stock
(NQ:
MGX
)
1.250
+0.060 (+5.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
208,646
Open
1.210
Bid (Size)
1.190 (100)
Ask (Size)
1.300 (300)
Prev. Close
1.190
Today's Range
1.210 - 1.305
52wk Range
1.130 - 3.950
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference
May 28, 2026
From
Metagenomi Therapeutics, Inc.
Via
GlobeNewswire
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
May 11, 2026
From
Metagenomi Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
-25.1%
-25.1%
1 Month
-7.4%
-7.4%
3 Month
-5.3%
-5.3%
6 Month
-26.5%
-26.5%
1 Year
-21.4%
-21.4%
More News
Read More
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
April 16, 2026
From
Metagenomi Therapeutics, Inc.
Via
GlobeNewswire
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
March 05, 2026
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
February 23, 2026
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
January 12, 2026
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
December 01, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Present at Jefferies Global Healthcare Conference in London
November 17, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Prioritizes Hemophilia A Program, Lays Off 25% Workforce
↗
November 12, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
November 12, 2025
Via
Benzinga
These stocks are moving in today's after hours session
↗
November 11, 2025
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
November 11, 2025
Via
Benzinga
Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates
November 11, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development
November 11, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected
↗
August 12, 2025
Via
Chartmill
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
August 12, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
August 11, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Which stocks are gapping on Wednesday?
↗
July 09, 2025
Via
Chartmill
Sam Altman Says He 'Didn't Think' Elon Musk Would Abuse Government Power, Tesla CEO Hits Back With 'Scam Altman' Jibe
↗
June 20, 2025
Via
Benzinga
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
↗
June 18, 2025
Via
Benzinga
Demystifying Metagenomi: Insights From 4 Analyst Reviews
↗
May 15, 2025
Via
Benzinga
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
↗
May 15, 2025
Via
Benzinga
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
May 14, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results
May 13, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Present at Upcoming Scientific Meetings
May 02, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Metagenomi Therapeutics, Inc. - Common Stock publicly traded?
Yes, Metagenomi Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Metagenomi Therapeutics, Inc. - Common Stock trade on?
Metagenomi Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Metagenomi Therapeutics, Inc. - Common Stock?
The ticker symbol for Metagenomi Therapeutics, Inc. - Common Stock is MGX on the Nasdaq Stock Market
What is the current price of Metagenomi Therapeutics, Inc. - Common Stock?
The current price of Metagenomi Therapeutics, Inc. - Common Stock is 1.250
When was Metagenomi Therapeutics, Inc. - Common Stock last traded?
The last trade of Metagenomi Therapeutics, Inc. - Common Stock was at 06/26/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
